Steven E. Kahn
University of Washington
Steven Emanuel Kahn is Professor of Medicine at the University of Washington and at the VA Puget Sound Health Care System. He is also Director of the University of Washington Diabetes Research Center and Director of the Diabetes Research Group at VA Puget Sound Health Care System.
Read biography ↓Biography, research & contributions
Steven Emanuel Kahn is Professor of Medicine at the University of Washington and at the VA Puget Sound Health Care System. He is also Director of the University of Washington Diabetes Research Center and Director of the Diabetes Research Group at VA Puget Sound Health Care System.
Affiliation
University of Washington
Top Publications
- Mechanisms linking obesity to insulin resistance and type 2 diabetes (2006) - 5,528 citations
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) - 3,104 citations
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy (2006) - 2,971 citations
- The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes (2003) - 2,178 citations
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2013) - 1,793 citations
At a glance
- Full name
- Steven E. Kahn
- ORCID
- 0000-0001-7307-9002
- OpenAlex ID
- https://openalex.org/A5066700951
Research interests
- Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Pancreatic function and diabetes, Diabetes Management and Research, Diabetes and associated disorders
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- 5,528OpenAlex citations
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes ↗2023 · New England Journal of Medicine3,104OpenAlex citations
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy ↗2006 · New England Journal of Medicine2,971OpenAlex citations
- 2,178OpenAlex citations
- 1,793OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes ↗2023 · New England Journal of Medicine
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy ↗2006 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:45:30
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.